Successful Treatment of Severe Type B Lactic Acidosis in a Patient with HIV/AIDS-Associated High-Grade NHL.
Marco MejiaAriel PerezHarold WatsonDaniel SanchezJorge ParelladaMario MadrugaStephen J CarlanPublished in: Case reports in immunology (2018)
Type B lactic acidosis is a rare metabolic complication sometimes associated with hematologic malignancies. When present, this type of lactic acidosis is most commonly seen in patients with high-grade lymphomas or leukemias and is usually indicative of a dismal prognosis. We report a case of a 27-year man with acquired immunodeficiency syndrome (AIDS) that presented with bilateral lower extremity swelling, an abdominal mass, and weight loss. His lab values showed elevated anion gap with lactic acidosis and computed tomography (CT) of the abdomen showed a large soft-tissue mass arising from the left hepatic lobe. Biopsy of the abdominal mass demonstrated a high-grade diffuse large B-cell lymphoma. The patient's lactic acidosis resolved after starting chemotherapy, and a complete response was evident on PET-CT after a third cycle of rituximab, etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin (EPOC-RR). Care-givers should be aware of the implications of lactic acidosis associated with malignancy and the need for prompt diagnosis and treatment.
Keyphrases
- high grade
- diffuse large b cell lymphoma
- pet ct
- hiv aids
- computed tomography
- low grade
- case report
- positron emission tomography
- weight loss
- antiretroviral therapy
- epstein barr virus
- soft tissue
- healthcare
- bariatric surgery
- magnetic resonance imaging
- low dose
- type diabetes
- dual energy
- high dose
- squamous cell carcinoma
- drug delivery
- magnetic resonance
- early onset
- roux en y gastric bypass
- image quality
- human immunodeficiency virus
- health insurance